Baird Downgrades Third Wave (TWTI) to Neutral
Baird downgrades Third Wave (Nasdaq: TWTI) from Outperform to Neutral, saying merger with Hologic seems solid...don't see other bidders emerging. Price target $12.
Third Wave Technologies, Inc. (Third Wave) develops and markets molecular diagnostics for a variety of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) analysis applications for clinical, research and agricultural customers.
Related Categories
DowngradesStocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
